Regulatory Relief to Promote Domestic Production of Critical Medicines

The order directs federal agencies to streamline regulations and facilitate domestic production of critical pharmaceutical products. Specifically, the Secretary of Health and Human Services, through the Commissioner of Food and Drugs, is to review existing regulations and guidance within 180 days, eliminating any unnecessary requirements and accelerating the development of domestic pharmaceutical manufacturing. The order also instructs the FDA Commissioner to improve the inspection process of foreign manufacturing facilities within 90 days.